20190201163JC/Jilin Scientific and Technological Development Program[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.

Tian M, Liang X, Xu W, Yi X, Yue T, Zhang Y, Yu S, Yan Y, Hu Z, Zhang N, Wang J, Hu R, Sun X, Nie Y, Dai Y, Jin F. Tian M, et al. Ann Hematol. 2023 Oct;102(10):2943-2945. doi: 10.1007/s00277-023-05362-8. Epub 2023 Jul 12. Ann Hematol. 2023. PMID: 37434095 No abstract available.

Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma.

Liu S, Zhou H, Xu W, Jin T, Liang X, Zhao X, Dai Y, Jin F. Liu S, et al. Ann Hematol. 2023 Apr;102(4):967-969. doi: 10.1007/s00277-023-05120-w. Epub 2023 Feb 8. Ann Hematol. 2023. PMID: 36752844 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters